Integrin αIIIa inhibitors are a class of chemical compounds that specifically target the integrin αIIIa, a subunit of the integrin family of cell surface receptors involved in cell adhesion, migration, and signaling. Integrins are heterodimeric proteins, meaning they are composed of two distinct subunits: an alpha (α) and a beta (β) subunit. These receptors play crucial roles in connecting cells to the extracellular matrix (ECM) and facilitating interactions between cells and their surrounding environment. Integrin αIIIa is typically paired with specific β subunits to form functional receptors that mediate binding to ligands such as fibrinogen, fibronectin, and other components of the ECM. By doing so, integrin αIIIa is involved in regulating cellular adhesion, shape, and migration, influencing processes such as wound healing, tissue remodeling, and immune responses. Inhibitors of integrin αIIIa are designed to block these interactions, altering the integrin's ability to mediate such cellular processes.
The design of integrin αIIIa inhibitors focuses on disrupting the specific binding sites within the αIIIa subunit that are essential for its interactions with ligands or other ECM components. These inhibitors may function by binding to the receptor's active site, preventing the conformational changes necessary for integrin activation, or by occupying the ligand-binding pocket, thereby blocking the attachment of ECM molecules. The interaction between integrin αIIIa inhibitors and the receptor is often mediated by non-covalent forces such as hydrogen bonds, van der Waals interactions, and hydrophobic interactions, ensuring specific and stable binding. By inhibiting integrin αIIIa, researchers can explore how this integrin regulates cellular adhesion and migration, providing deeper insights into the role of integrins in maintaining tissue architecture and facilitating communication between cells and their microenvironment. These inhibitors are valuable tools for studying integrin-mediated cellular behaviors and how integrin dysfunction can affect broader biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could downregulate ITGA3 by suppressing nuclear factor-kappa B (NF-κB), a transcription factor involved in the expression of various integrins. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may decrease ITGA3 expression through the activation of sirtuin 1 (SIRT1), leading to histone deacetylation and transcriptional repression of the ITGA3 gene. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein could inhibit ITGA3 expression by blocking tyrosine kinases that are critical for the transcriptional activation of the ITGA3 gene. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin might reduce ITGA3 expression by attenuating signal transducer and activator of transcription 3 (STAT3) signaling, which is known to drive the expression of certain integrins. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may downregulate ITGA3 expression by activating the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway, which can repress certain cell adhesion molecules. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate might inhibit ITGA3 expression by interfering with the fibroblast growth factor (FGF) signaling pathway, leading to reduced transcriptional activity of ITGA3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid may reduce ITGA3 expression by binding to retinoic acid receptors (RARs) that heterodimerize with retinoid X receptors (RXRs), which can repress the ITGA3 promoter activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could lead to the downregulation of ITGA3 by causing DNA demethylation in the gene's promoter region, thereby silencing its transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A can decrease ITGA3 expression by inhibiting histone deacetylases (HDACs), which results in a more condensed chromatin structure around the ITGA3 gene, limiting its expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may reduce ITGA3 transcription by inhibiting the phosphatidylinositol 3-kinase (PI3K) pathway, resulting in decreased activity of transcription factors that elevate ITGA3 levels. | ||||||